Emergent Biosolutions (EBS) Misses Q3 EPS by 4c, Reaffirms
More News related to EBS
- Emergent BioSolutions (EBS) Acquires MdBio Foundation Facility and Land for $8.2M
- Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
- Emergent Biosolutions (EBS) Misses Q3 EPS by 4c, Reaffirms
- Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2009
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
More News related to Earnings
- Central European Distribution (CEDC) Prices $380M Senior Secured Notes
- Washington Banking (WBCO) Prices 5M Common Offering at $9/Share
- AEGON (AEG) Announces $500M Unsecured Senior Note Offering
- Compellent Technologies (CML) Completes 3.84 Million Share Offering
- Advanced Micro Devices (AMD) To Sell $500M of Senior Notes in Private Offering
Emergent Biosolutions Inc (NYSE: EBS) reports Q3 EPS of $0.03, 4 cents below the analyst estimate of $0.07. Revenue for the quarter was $43.3 million, which compares to the estimate of $49.56 million.
Reaffirms FY09 sales
Related Categories
EarningsStocks Mentioned
+0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
